Pancreatic mucinous cystic neoplasms with sarcomatous stroma: Molecular evidence for monoclonal origin with subsequent divergence of the epithelial and sarcomatous components

Modern Pathology

Volumn 13, Issue 1, 2000, Pages 86-91

  Van Den Berg, Wiebren ^a   Tascilar, Metin ^a   Offerhaus, G Johan A ^a   Albores Saavedra, Jorge ^b   Wenig, Bruce M ^c   Hruban, Ralph H ^c   Gabrielson, Edward ^c,d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Carcinosarcoma; K ras; Loss of heterozygosity; Neoplasms; Pancreas

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; AUTORADIOGRAPHY; CANCER DIAGNOSIS; DATA ANALYSIS; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; ONCOGENE K RAS; PANCREAS TUMOR; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SARCOMA;

EID: 0033980242     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880013     Document Type: Article

References (33)

1. Wick MR, Swanson PE. Carcinosarcomas: current perspectives and an historical review of nosological concepts. Semin Diagn Pathol 1993;10:118-27.
2. Zarbo RJ, Crissman JD, Venkat H, Weiss MA. Spindle-cell carcinoma of the upper aerodigestive tract mucosa. An immunohistologic and ultrastructural study of 18 biphasic tumors and comparison with seven monophasic spindle-cell tumors. Am J Surg Pathol 1986;10:741-53.
3. Leman BI, Walker PD. Sarcomatoid carcinoma of the pancreas. Am J Clin Pathol 1981;76:351.
4. Bauer TW, Rostock RA, Eggleston JC, Baral E. Spindle cell carcinoma of the breast: four cases and review of the literature. Hum Pathol 1984;15:147-52.
5. Humphrey PA, Scroggs MW, Roggli VL, Shelburne JD. Pulmonary carcinomas with a sarcomatoid element: an immu nocytochemical and ultrastructural analysis. Hum Pathol 1988;19:155-65.
6. Young RH, Wick MR, Mills SE. Sarcomatoid carcinoma of the urinary bladder: a clinicopathologic analysis of 12 cases and review of the literature. Am J Clin Pathol 1988;90:653-61.
7. Ro JY, Chen JL, Lee JS, Sahin AA, Ordonez NG, Ayala AG. Sarcomatoid carcinoma of the lung. Immunohistochemical and ultrastructural studies of 14 cases. Cancer 1992;69:376-86.
8. Bitterman P, Chun B, Kurman RJ. The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. A clinicopathologic and immunohistochemical study. Am J Surg Pathol 1990;14:317-28.
9. Clement PB, Scully RE. Uterine tumors with mixed epithelial and mesenchymal elements. Semin Diagn Pathol 1988;5: 199-222.
10. Reuter VE. Sarcomatoid lesions of the urogenital tract. Semin Diagn Pathol 1993;10:188-201.
11. Lauwers GY, Schevchuk M, Armenakas N, Reuter VE. Carcinosarcoma of the prostate. Am J Surg Pathol 1993;17:342-9.
12. Westra WH, Sturm PJ, Drillenburg P, Choti MA, Klimstra DS, Abores-Saavedra J, et al. K-ras oncogene mutations in osteoclast-like giant-cell tumors of the pancreas and liver: genetic evidence to support origin from the duct epithelium. Am J Surg Pathol 1998;22:1247-54.
13. Wenig BM, Albores-Saavedra J, Buetow PC, Heffess CS. Pancreatic mucinous cystic neoplasm with sarcomatous stroma: a report of three cases. Am J Surg Pathol 1997;21:70-80.
14. Hahn SA, Seymour AB, Hoque ATMS, Schutte M, da Costa LT, Redston MS, et al. Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res 1995;55:4670-5.
15. Seymour A, Hruban RH, Redston MS, Caldas C, Powell SM, Kinzler KW, et al. Allelotype of pancreatic adenocarcinoma. Cancer Res 1994;54:2761-4.
16. Hruban RH, van Mansfeld ADM, Offerhaus GJA, van Weering DHJ, Allison DC, Goodman SN, et al. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligo-nucleotide hybridization. Am J Pathol 1993;143:545-54.
17. Fujii H, Inagaki M, Kasai S, Miyokawa N, Tokusashi Y, Gabrielson E, et al. Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 1997;151:1447-54.
18. Fujii H, Marsh C, Cairns P, Sidransky D, Gabrielson E. Genetic divergence in the clonal evolution of breast cancer. Cancer Res 1996;56:1493-7.
19. Fujii H, Szumel R, Marsh C, Zhou W, Gabrielson E. Genetic progression, histological grade and allelic loss in ductal carcinoma in situ of the breast. Cancer Res 1996;56:5260-5.
20. Hruban RH, Sturm PDJ, Slebos RJC, Wilentz RE, Musler AR, van Velthuysen ML, et al. Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients. Am J Pathol 1997;151:943-9.
21. Fearon ER, Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw Hill; 1997. pp. 229-36.
22. Kinzler KW, Vogelstein B. Gatekeepers and caretakers. Nature 1997;386:761-3.
23. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
24. Tsao J, Tavare S, Salovaara R, Jass JR, Aaltonen LA, Shibata D. Colorectal adenoma and cancer divergence. Am J Pathol 1999;154:1815-24.
25. Redston MS, Caldas C, Seymour AB, Hruban RH, da Costa L, Yeo CJ, et al. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res 1994;54:3025-33.
26. DiGiuseppe JA, Hruban RH, Goodman SN, Polak M, van den Berg FM, Allison DC, et al. Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol 1994;101: 684-8.
27. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 1994;8:27-32.
28. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, daCosta LT, Rozenblum E, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;271:350-3.
29. Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, et al. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res 1997;57:1731-4.
30. Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, et al. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 1997;57:3126-30.
31. Hruban RH, Petersen GM, Ha PK, Kern SE. Genetics of pancreatic cancer: from genes to families. Surg Oncol Clin N Am 1998;7:1-23.
32. Thompson LDR, Becker RC, Przygodzki RM, Adair CF, Heffess CS. Mucinous cystic neoplasm (mucinous cystadeno-carcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of the pancreas. Am J Surg Pathol 1999;23:1-16.
33. Wilentz RE, Albores-Saavedra J, Zahurak M, Talamini MA, Yeo CJ, Cameron JL, et al. Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas. Am J Surg Pathol 1999;23:1320-7.